Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.

ABSTRACT: This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV (PWH) demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain (RBD) antibody titres after two doses, despite varied titres after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.

SUBMITTER: Ruddy JA 

PROVIDER: S-EPMC10323870 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature